Works about EDOXABAN

Results: 132

Edoxaban in cardiovascular medicine from scientific evidence to clinical practice.

Published in:

Turkish Journal of Vascular Surgery (TJVS), 2022, v. 31, n. 3, p. 195, doi. 10.9739/tjvs.2022.09.019

By:

Budak, Ali Baran;
Gencpinar, Tugra;
Dogan, Emre;
Totan, Sahin;
Akay, Hakki Tankut

Publication type:

Article

Multicenter observational study on anticoagulation-related bleeding events in emergency department patients.

Published in:

Journal of Research in Pharmacy, 2024, v. 28, n. 6, p. 2243, doi. 10.29228/jrp.898

By:

ÇAKMAK, Sümeyye;
SÖĞÜT, Özgür;
İLHAN, Buğra;
ŞİMŞEKOĞLU, Ruken;
ÜMİT, Tuba Betül;
DOĞAN, Halil;
ÜNLÜKAPLAN, Işık Melike

Publication type:

Article

Development and validation of a novel Spectrofluorimetric method of oral anticoagulant Edoxaban via derivatization with 9-fluorenyl methyl chloroformate: green assessment of the method by Eco-Scale and ComplexGAPI.

Published in:

BMC Chemistry, 2022, v. 16, n. 1, p. 1, doi. 10.1186/s13065-022-00890-2

By:

Rizk, Mohamed;
El-Alamin, Maha Mahmoud Abou;
Elkhalek, Ola Abd;
Shallan, Aliaa I.

Publication type:

Article

A Pilot Study to Evaluate an International Normalized Ratio-Derived Formula in Combination with Heparin-Calibrated Anti-Xa Activity in Calculating a Plasma Edoxaban Level.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 1006, doi. 10.3390/jcm14031006

By:

Sin, Chun-Fung;
Chan, Pui-Yee;
Hoo, Yi-Teng;
Yuen, Wang-Ho;
Wong, Hoi-Ching

Publication type:

Article

Prothrombotic Rebound After Discontinuation of Direct Oral Anticoagulants Therapy: A Systematic Review.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 21, p. 6606, doi. 10.3390/jcm13216606

By:

Frydrych, Marta;
Janeczek, Maciej;
Małyszek, Agata;
Nelke, Kamil;
Dobrzyński, Maciej;
Lukaszewski, Marceli

Publication type:

Article

Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 1870, doi. 10.3390/jcm12051870

By:

Chao, Tze-Fan;
Unverdorben, Martin;
Kirchhof, Paulus;
Koretsune, Yukihiro;
Yamashita, Takeshi;
Crozier, Robert A.;
Pecen, Ladislav;
Chen, Cathy;
Borrow, Amanda P.;
De Caterina, Raffaele

Publication type:

Article

A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1945, doi. 10.3390/jcm11071945

By:

Patti, Giuseppe;
Parato, Vito Maurizio;
Cavallari, Ilaria;
Calabrò, Paolo;
Russo, Vincenzo;
Renda, Giulia;
Gragnano, Felice;
Pengo, Vittorio;
D'Onofrio, Antonio;
Grimaldi, Massimo;
De Caterina, Raffaele

Publication type:

Article

Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 22, p. 5337, doi. 10.3390/jcm10225337

By:

Choi, Eue-Keun;
Lin, Wei-Shiang;
Hwang, Gyo-Seung;
Kirchhof, Paulus;
De Caterina, Raffaele;
Chen, Cathy;
Unverdorben, Martin;
Wang, Chun-Chieh;
Kim, Young-Hoon

Publication type:

Article

Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro ® Clotting Time: An Ex Vivo Spiking Study in A Cohort of Trauma Patients.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3476, doi. 10.3390/jcm10163476

By:

Oberladstätter, Daniel;
Schlimp, Christoph J.;
Zipperle, Johannes;
Osuchowski, Marcin F.;
Voelckel, Wolfgang;
Grottke, Oliver;
Schöchl, Herbert

Publication type:

Article

Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 13, p. 2879, doi. 10.3390/jcm10132879

By:

Boriani, Giuseppe;
De Caterina, Raffaele;
Manu, Marius Constantin;
Souza, José;
Pecen, Ladislav;
Kirchhof, Paulus

Publication type:

Article

Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 573, doi. 10.3390/jcm10040573

By:

De Caterina, Raffaele;
Kim, Young-Hoon;
Koretsune, Yukihiro;
Wang, Chun-Chieh;
Yamashita, Takeshi;
Chen, Cathy;
Reimitz, Paul-Egbert;
Unverdorben, Martin;
Kirchhof, Paulus;
Dichtl, Wolfgang;
Duru, Firat

Publication type:

Article

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1621, doi. 10.3390/jcm9061621

By:

Russo, Vincenzo;
Attena, Emilio;
Rago, Anna;
Melillo, Enrico;
Di Micco, Pierpaolo;
Papa, Andrea Antonio;
Napolitano, Giovanni;
D'Onofrio, Antonio;
Golino, Paolo;
Nigro, Gerardo

Publication type:

Article

Does Prophylactic Administration of Edoxaban Increase D-Dimer Levels after Total Hip Arthroplasty?

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 5, p. 678, doi. 10.3390/jcm8050678

By:

Kawai, Toshiyuki;
Kuroda, Yutaka;
Goto, Koji;
Matsuda, Shuichi

Publication type:

Article

Cerebellar hemorrhage in patients treated with edoxaban for portal vein thrombosis after hepatobiliary surgery: a report of two cases.

Published in:

Surgical Case Reports, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40792-020-01086-3

By:

Iida, Hiroya;
Miyake, Toru;
Tani, Masaji;
Tanaka, Takuya;
Kawakami, Kayo;
Ikuno, Yoshihiro;
Mandai, Ryoichi;
Shimizu, Tomoharu

Publication type:

Article

Validation of a whole blood coagulometer sensitive to the direct oral anticoagulants.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-92201-7

By:

Bakhru, Sasha H.;
Jiang, Xuan;
Chen, Lirong;
Osmani, Dardan;
Kronen, Kelly;
Mootoo, Daryl;
Zappe, Stefan;
Ansell, Jack

Publication type:

Article

Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1440, doi. 10.1002/cpdd.1156

By:

Liu, Lihua;
Li, Xin;
Liu, Yujie;
Xu, Bing;
Li, Yuan;
Yuan, Fang;
Zhang, Ping;
Tu, Shengqing;
Hu, Wenhui

Publication type:

Article

Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 666, doi. 10.1002/cpdd.1050

By:

Yin, Ophelia;
Kakkar, Tarundeep;
Duggal, Anil;
Kotsuma, Masakatsu;
Shi, Minggao;
Lanz, Hans;
Grosso, Michael A.

Publication type:

Article

Population Pharmacokinetics of Edoxaban in Japanese Atrial Fibrillation Patients With Severe Renal Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 484, doi. 10.1002/cpdd.329

By:

Shimizu, Takako;
Tachibana, Masaya;
Kimura, Tetsuya;
Kumakura, Tomohiko;
Yoshihara, Kazutaka

Publication type:

Article

Protocol for LASER: A Randomized Evaluation and an Associated Registry of Early Anticoagulation With Edoxaban After Ischemic Stroke in Patients With Atrial Fibrillation.

Published in:

Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.645822

By:

Alrohimi, Anas;
Jickling, Glen;
Jeerakathil, Thomas;
Shuaib, Ashfaq;
Khan, Khurshid;
Kate, Mahesh;
Hill, Michael D.;
Buck, Brian;
Butcher, Ken

Publication type:

Article

Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.

Published in:

Molecular Medicine Reports, 2017, v. 16, n. 5, p. 7706, doi. 10.3892/mmr.2017.7574

By:

WEI SONG;
HONGBO CI;
GUANGLEI TIAN;
XIAOHU GE;
YANJUN ZHANG

Publication type:

Article

Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation.

Published in:: Annals of Internal Medicine, 2023, v. 176, n. 1, p. 144, doi. 10.7326/L22-0482
Publication type:: Article

Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study.

Published in:

2022

By:

Lau, Wallis C.Y.;
Torre, Carmen Olga;
Man, Kenneth K.C.;
Stewart, Henry Morgan;
Seager, Sarah;
Van Zandt, Mui;
Reich, Christian;
Li, Jing;
Brewster, Jack;
Lip, Gregory Y.H.;
Hingorani, Aroon D.;
Wei, Li;
Wong, Ian C.K.

Publication type:

journal article

In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleeding.

Published in:

2022

By:

Colivicchi, Furio

Publication type:

journal article

Impact of Age and Factor Xa Inhibitor Concentrations on Bleeding Risk in Patients with Atrial Fibrillation.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 156, doi. 10.1002/cpt.3654

By:

Lin, Shin‐Yi;
Liu, Yen‐Bing;
Ho, Li‐Ting;
Kuo, Ching‐Hua;
Peng, Yu‐Fong;
Huang, Chih‐Fen;
Tang, Sung‐Chun;
Jeng, Jiann‐Shing

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, and Safety of Edoxaban in Pediatric Subjects: A Phase I Single‐Dose Study.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 736, doi. 10.1002/cpt.3196

By:

Zou, Peng;
Zahir, Hamim;
Duggal, Anil;
Pandya, Grishma;
Jin, James;
Leil, Tarek A.

Publication type:

Article

Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Published in:

Medicines, 2023, v. 10, n. 1, p. 13, doi. 10.3390/medicines10010013

By:

Wang, Yapeng;
Li, Li;
Wei, Zhanlan;
Lu, Shan;
Liu, Wenxue;
Zhang, Janghui;
Feng, Junbo;
Wang, Dongjin

Publication type:

Article

Edoxaban-related Spontaneous Renal Hematoma: A Case Report.

Published in:

2020

By:

Iplikci, Ayberk;
Efiloglu, Ozgur;
Yildirim, Asif

Publication type:

Case Study

Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241303758

By:

Xiao, Xiulin;
Zhu, Wengen;
Dai, Qixin

Publication type:

Article

Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241260728

By:

Unverdorben, Martin;
Colonna, Paolo;
Jin, James;
Köhler, Sabine;
Santamaria, Amparo;
Saxena, Manish;
Borrow, Amanda;
Chen, Cathy;
von Heymann, Christian;
Vanassche, Thomas

Publication type:

Article

Challenges to Laboratory Monitoring of Direct Oral Anticoagulants.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241241524

By:

Qiao, Jesse;
Tran, Minh-Ha

Publication type:

Article

Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231200223

By:

Santamaria, Amparo;
Chen, Cathy;
Colonna, Paolo;
von Heymann, Christian;
Saxena, Manish;
Vanassche, Thomas;
Jin, James;
Unverdorben, Martin

Publication type:

Article

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231180865

By:

Olivera, Pável;
Velásquez-Escandón, César;
Campoy, Desirée;
Flores, Katia;
Canals, Tania;
Johansson, Erik;
Herranz, María José;
Martínez, Laia;
Cerezo-Manchado, Juan José;
Salinas, Ramón

Publication type:

Article

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221138297

By:

Mehrotra, Siddharth;
Hoppensteadt, Debra;
Jeske, Walter;
Siddiqui, Fakiha;
Iqbal, Omer;
Tafur, Alfonso;
Lewis, Bruce;
Jaradeh, Mark;
Kantarcioglu, Bulent;
Fareed, Jawed

Publication type:

Article

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2020, v. 26, p. 1, doi. 10.1177/1076029620948585

By:

Sokol, Juraj;
Nehaj, Frantisek;
Ivankova, Jela;
Mokan, Michal;
Lisa, Lenka;
Zolkova, Jana;
Vadelova, Lubica;
Mokan, Marian;
Stasko, Jan

Publication type:

Article

Plasmatic variability of direct oral anticoagulants in people with atrial fibrillation and previous gastric surgery: a pilot case series.

Published in:

Neurological Sciences, 2025, v. 46, n. 4, p. 1715, doi. 10.1007/s10072-024-07937-3

By:

Romoli, Michele;
Vitiello, Maria;
Lotti, Enrico Maria;
D'Antuono, Giuseppe;
Berardo, Arianna;
Faini, Claudia;
Tudisco, Valentina;
Mastrangelo, Vincenzo;
Longoni, Marco

Publication type:

Article

Edoxaban improves atrial fibrillation and thromboembolism through regulation of the Wnt-β-induced PI3K/ATK-activated protein C system.

Published in:

Experimental & Therapeutic Medicine, 2019, v. 17, n. 5, p. 3509

By:

Shan, Xuefeng;
Liu, Zhiqiang;
Wulasihan, Muhuyati;
Ma, Songfeng

Publication type:

Article

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60235-y

By:

Tadokoro, Tomoko;
Tani, Joji;
Manabe, Takushi;
Takuma, Kei;
Nakahara, Mai;
Oura, Kyoko;
Mimura, Shima;
Fujita, Koji;
Nomura, Takako;
Morishita, Asahiro;
Kobara, Hideki;
Himoto, Takashi;
Ono, Masafumi;
Masaki, Tsutomu

Publication type:

Article

Evaluation of Drug–Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models.

Published in:

Pharmaceutics, 2024, v. 16, n. 11, p. 1449, doi. 10.3390/pharmaceutics16111449

By:

Yang, Zhuan;
Qu, Yuchen;
Sun, Yewen;
Pan, Jie;
Zhou, Tong;
Yu, Yunli

Publication type:

Article

In-Hospital Mechanical Thrombectomy: A Case Report.

Published in:

Case Reports in Neurology, 2020, v. 12, p. 22, doi. 10.1159/000501001

By:

Lee, Tsong-Hai

Publication type:

Article

Validated and selective potentiometric analysis of anti-coagulant edoxaban via a screen-printed electrode: green assessment by Eco-Scale and Complex-GAPI.

Published in:

Journal of the Iranian Chemical Society, 2023, v. 20, n. 9, p. 2319, doi. 10.1007/s13738-023-02842-6

By:

Rizk, Mohamed;
Abou El-Alamin, Maha Mahmoud;
Abd Elkhalek, Ola;
Shallan, Aliaa I.

Publication type:

Article

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h.

Published in:

European Heart Journal, 2024, v. 45, n. 10, p. 837, doi. 10.1093/eurheartj/ehad771

By:

Becher, Nina;
Toennis, Tobias;
Bertaglia, Emanuele;
Blomström-Lundqvist, Carina;
Brandes, Axel;
Cabanelas, Nuno;
Calvert, Melanie;
Camm, A John;
Chlouverakis, Gregory;
Dan, Gheorghe-Andrei;
Dichtl, Wolfgang;
Diener, Hans Christoph;
Fierenz, Alexander;
Goette, Andreas;
Groot, Joris R de;
Hermans, Astrid N L;
Lip, Gregory Y H;
Lubinski, Andrzej;
Marijon, Eloi;
Merkely, Béla

Publication type:

Article

Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.

Published in:

Xenobiotica, 2019, v. 49, n. 9, p. 1001, doi. 10.1080/00498254.2018.1524188

By:

Ota, Miki;
Notsu, Yuki;
Shimizu, Makiko;
Yamazaki, Hiroshi;
Yamazaki-Nishioka, Miho;
Kogiku, Minoru;
Noda, Masayuki;
Endo, Sumio;
Takekawa, Mitsuru;
Kishi, Hirohisa

Publication type:

Article

Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.

Published in:

BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10403-y

By:

Nakamura, Michio;
Ishiguro, Atsushi;
Dazai, Masayoshi;
Kawamoto, Yasuyuki;
Yuki, Satoshi;
Sogabe, Susumu;
Hosokawa, Ayumu;
Sawada, Kentaro;
Muto, Osamu;
Izawa, Naoki;
Nakashima, Koji;
Horie, Yoshiki;
Yagisawa, Masataka;
Kajiura, Shinya;
Ando, Takayuki;
Mitsuhashi, Yosuke;
Sunakawa, Yu;
Kikuchi, Yasuka;
Komatsu, Yoshito

Publication type:

Article

Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study.

Published in:

BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10403-y

By:

Nakamura, Michio;
Ishiguro, Atsushi;
Dazai, Masayoshi;
Kawamoto, Yasuyuki;
Yuki, Satoshi;
Sogabe, Susumu;
Hosokawa, Ayumu;
Sawada, Kentaro;
Muto, Osamu;
Izawa, Naoki;
Nakashima, Koji;
Horie, Yoshiki;
Yagisawa, Masataka;
Kajiura, Shinya;
Ando, Takayuki;
Mitsuhashi, Yosuke;
Sunakawa, Yu;
Kikuchi, Yasuka;
Komatsu, Yoshito

Publication type:

Article

Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease.

Published in:

Journal of Interventional Cardiology, 2022, v. 2022, p. 1, doi. 10.1155/2022/5905022

By:

Fukamachi, Daisuke;
Okumura, Yasuo;
Matsumoto, Naoya;
Tachibana, Eizo;
Oiwa, Koji;
Ichikawa, Makoto;
Haruta, Hironori;
Nomoto, Kazumiki;
Arima, Ken;
Hirayama, Atsushi

Publication type:

Article

Prothrombinase-Induced Clotting Time to Measure Drug Concentrations of Rivaroxaban, Apixaban, and Edoxaban in Clinical Practice: A Cross-Sectional Study.

Published in:

Life (2075-1729), 2022, v. 12, n. 7, p. 1027, doi. 10.3390/life12071027

By:

Sathanantham, Vepusha;
Alberio, Lorenzo;
Bovet, Cédric;
Fontana, Pierre;
Gerber, Bernhard;
Graf, Lukas;
Mendez, Adriana;
Sauter, Thomas C.;
Schmidt, Adrian;
Studt, Jan-Dirk;
Wuillemin, Walter A.;
Nagler, Michael

Publication type:

Article

Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation.

Published in:

Drugs in R&D, 2022, v. 22, n. 4, p. 281, doi. 10.1007/s40268-022-00403-5

By:

Ono, Ryohei;
Nishimura, Kazutaka;
Takahashi, Hidehisa;
Hori, Yasuhiko;
Fukushima, Kenichi;
Kobayashi, Yoshio

Publication type:

Article

Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants such as Apixaban, Rivaroxaban, and Edoxaban.

Published in:

Clinical Laboratory, 2024, v. 70, n. 9, p. 1682, doi. 10.7754/Clin.Lab.2024.240314

By:

Hyo-Suk Ahn;
Hyojin Chae;
Yeongsic Kim;
Hey Kyung Lee;
Hyunjung Kim

Publication type:

Article

Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8727, doi. 10.3390/ijms25168727

By:

Jannati, Shirin;
Patnaik, Rajashree;
Banerjee, Yajnavalka

Publication type:

Article

Treatment with Edoxaban Attenuates Acute Stroke Severity in Mice by Reducing Blood–Brain Barrier Damage and Inflammation.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 18, p. 9893, doi. 10.3390/ijms22189893

By:

Bieber, Michael;
Foerster, Kathrin I.;
Haefeli, Walter E.;
Pham, Mirko;
Schuhmann, Michael K.;
Kraft, Peter

Publication type:

Article